Please login to the form below

Not currently logged in
Email:
Password:

flu

This page shows the latest flu news and features for those working in and with pharma, biotech and healthcare.

US backs Sanofi’s ‘fast-track’ coronavirus vaccine

US backs Sanofi’s ‘fast-track’ coronavirus vaccine

agreement with BARDA to produce vaccines for pandemic flu outbreaks.

Latest news

  • GSK and Gilead join global efforts to tackle novel coronavirus GSK and Gilead join global efforts to tackle novel coronavirus

    Our adjuvant technology has previously been used successfully in the pandemic flu setting.

  • Dupixent gains can’t keep Sanofi on a growth track Dupixent gains can’t keep Sanofi on a growth track

    Third-quarter results revealed vaccine sales down almost 10% to 1.9bn – which it blamed on a delay by the World Health Organisation (WHO) on publishing the flu strains for inclusion

  • Externalities Externalities

    Let’s briefly look at two such examples. Suppose, for a moment, that I get an annual influenza vaccine or flu shot. ... Hence, the act of my getting a flu vaccine grants you and others in my circle a level of herd immunity.

  • UK rations AZ’s paediatric flu vaccine after delivery delays UK rations AZ’s paediatric flu vaccine after delivery delays

    Supplies may be limited as flu season begins. Delays in the release of some batches of AstraZeneca’s paediatric flu vaccine – Fluenz Tetra – means supplies may be limited as the ... The new policy has added another 600, 000 children to the 25

  • Roche scores another FDA approval for Xofluza Roche scores another FDA approval for Xofluza

    Expands use to patients at high risk of flu-related complications. Roche’s Xofluza (baloxavir marboxil) has received FDA approval for use in people who have a high risk of developing ... It demonstrated that Xofluza significantly reduced the time of

More from news
Approximately 9 fully matching, plus 316 partially matching documents found.

Latest Intelligence

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    The company’s most advanced programme is a universal flu vaccine, VTP-100, which has just begun phase 2b trials.Vaccitech is also developing a clinical stage therapeutic vaccine for prostate ... We need new flu vaccine products that enable long-term

  • Case study: Break the flu cycle Case study: Break the flu cycle

    This piece established the value story for the brand. ‘Break the Flu Cycle’ meetings programme: . ... Online marketing drove meetings attendance and engagement. ‘Break the Flu Cycle’ PR programme: .

  • Case study: 'Just Ask' Case study: 'Just Ask'

    As the symptoms can be mistaken for illnesses like flu, basic awareness of the condition is fundamental to its successful treatment.

  • The false economy of following the leader The false economy of following the leader

    Pain relief brands settle for being like Nurofen, cold and flu brands settle for being like Lemsip, and the healthcare world keeps turning without disruption.

  • Deal Watch February 2017 Deal Watch February 2017

    The portfolio also includes Buscopan (antispasmodic), Suppositoria Glycerini (laxative) and expectorants for cough and flu, Mucothiol and Mucodyne.

More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics